Central Counterparty Clearing for OTC Derivatives
| Date: | To be published July 2010 |
| Author: | Sarah-Jane Dennis and David Reynolds |
| Price: | £3000 to non-members of the Investit Intelligence Member service |
In the aftermath of the recent financial crisis, the continued growth in Over the Counter (OTC) derivatives volumes has brought the need to guard against the systemic risks (ie the risk of a default of one firm spreading through the financial system) that result from the failure of a major market counterparty. OTC central counterparty clearing has been proposed as a way to establish this guard.
Against a backdrop of developing, but as yet to be enforced regulation, central counterparty clearing for over the counter derivatives is a hot topic and continues to receive significant interest from Intelligence member firms.
This “half paper” takes a detailed look at central counterparty clearing to satisfy the curiosity of our members and addresses:
- The nature of the OTC market and what makes it difficult to tame.
- The target model for central clearing and why it will not do all it says on the tin.
- The local and global challenges faced by regulators in striving towards a common approach to eligibility and cracking inter-operability.
- Investment manager’s perspectives, the thirst for knowledge as to what peers and service providers are doing.
- Implications for investment managers and their providers. Yes, there are benefits not just additional costs.
- Press release - Investment managers identify their key priorities
- Press release - Investit and Stone House Consulting announce a strategic partnership
- Press release - Investment managers identify their priorities for the year ahead
- See all press releases, articles and event information here
Enterprise Risk Management Intelligence report now available to read via Intelligence Online.
